Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Pulmonary Disease Caused by MAIS, M.Xenopi or M.Malmoense: A Comparison of Two Triple Drug Regimens and an Assessment of the Value of Immunotherapy With M.Vaccae

NCT00367913 is registered in ClinicalTrials.gov with British Thoracic Society as lead sponsor.

NCT NCT00367913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00367913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Pulmonary Disease Caused by MAIS, M.Xenopi or M.Malmoense: A Comparison of Two Triple Drug Regimens and an Assessment of the Value of Immunotherapy With M.Vaccae
Lead sponsor
British Thoracic Society
Phase
Phase 4
Overall status
Completed
Start date
March 31, 1995
Completion date
September 30, 2004
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary diseases